You searched for lung cancer | Page 45 of 173

Personalis and Tempus Collaborate to Advance Cancer Testing

Posted by Andy Lundin | Dec 4, 2023 | Cancer, Company News |

Personalis and Tempus Labs announced a collaboration to co-commercialize a whole genome-based liquid biopsy LDT for MRD and cancer detection.

Posted by Andy Lundin | Dec 1, 2023 | Lung Cancer, Swabs |

Clinical validation data shows that Veracyte’s Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.

Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.

Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.

Posted by Andy Lundin | Nov 2, 2023 | Cancer |

The TruSightf Oncology 500 ctDNA v2 enables comprehensive genomic profiling of ctDNA from blood when tissue testing is not available.